Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Kim SJ, Lim JQ, Laurensia Y, Cho J, Yoon SE, Lee JY, Ryu KJ, Ko YH, Koh Y, Cho D, Lim ST, Enemark MB, D'Amore F, Bjerre M, Ong CK, Kim WS.
Kim SJ, et al. Among authors: bjerre m.
Blood. 2020 Dec 10;136(24):2754-2763. doi: 10.1182/blood.2020007247.
Blood. 2020.
PMID: 32766875
Free article.
Clinical Trial.